(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride

(5R)-5-(4-{[(2-fluorophenyl)methyl]oxy}phenyl)-L-prolinamide, hydrochloride
Trade Name
Orphan Indication Erythromelalgia
USA Market Approval USA
USA Designation Date 2017-01-30 00:00:00
Sponsor Biogen, Inc.;300 Binney Street;Cambridge, Massachusetts, 02142
Related Access Program
Johns Hopkins University – Anemia University of Miami – Anemia Children’s Hospital of Philadelphia – Leukemia Steven M. Frank, MD – Anemia Atara Biotherapeutics – Epstein-Barr Virus-Associated Viremia Spectral Diagnostics (US) Inc. – Endotoxemia Hospital Ana Nery – Thromboembolism